Japheth Omwenga
Critical Care Medicine · Winter Garden, FLNPI 1457861551
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 46 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by AstraZeneca at 28.2% of the total.
Across 46 payments — averaging $84.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- GSK$659
- Jazz Pharmaceuticals Inc.$506
- Grifols USA, LLC$440
- Harmony Biosciences LLC$145
- Pulmonx Corporation$141
- plus $902 from 14 others
What the payments were for
- Food & beverage$3,891100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 11 | $1,098 |
| GSK | 8 | $659 |
| Jazz Pharmaceuticals Inc. | 4 | $506 |
| Grifols USA, LLC | 3 | $440 |
| Harmony Biosciences LLC | 2 | $145 |
| Pulmonx Corporation | 1 | $141 |
| La Jolla Pharmaceutical Company | 1 | $129 |
| Amgen | 1 | $126 |
| Idorsia Pharmaceuticals US Inc | 2 | $125 |
| Regeneron Healthcare Solutions, Inc. | 1 | $124 |
| Alkermes, Inc. | 2 | $122 |
| Axsome Therapeutics, Inc. | 2 | $114 |
| Vapotherm Inc | 1 | $28 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $22 |
| Mylan Specialty L.p. | 1 | $20 |
| Janssen Scientific Affairs, LLC | 1 | $20 |
| AbbVie | 1 | $19 |
| Johnson & Johnson | 1 | $18 |
| Baxter Healthcare | 1 | $18 |
| Paratek Pharmaceuticals, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NUCALA$598
- FASENRA$587
- XYWAV$383
- Prolastin-C Liquid$288
- BREZTRI$244
- Xembify$152
- CHARTIS CATHETER$141
- ZEPHYR DELIVERY CATHETER$141
- ZEPHYR ENDOBRONCHIAL VALVE$141
- PULMONX CHARTIS TABLET CONSOLE$141
- GIAPREZA$129
- TEZSPIRE$126
- IMFINZI$125
- DUPIXENT$124
- SUNOSI$123
- AIRSUPRA$122
- Wakix$113
- QUVIVIQ$101
How this compares
$3,891 in reported general payments places this provider in the 85th percentile of 618 critical care medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other critical care medicine in Winter Garden
- Louis GuzziOrlando$635K
- Fortune AlabiKissimmee$587K
- Debabrata BandyopadhyayTampa$398K
- Fred UmehKissimmee$371K
- Amit TandonWesley Chapel$338K
- Omid ZadOrlando$325K
- Eddy GutierrezJacksonville$315K
- Maximo LamaKissimmee$255K
- William CroleyPensacola$211K
- Nelson GomezBrandon$180K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.